BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22659092)

  • 1. Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10.
    Fedejko-Kap B; Bratton SM; Finel M; Radominska-Pandya A; Mazerska Z
    Drug Metab Dispos; 2012 Sep; 40(9):1736-43. PubMed ID: 22659092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic transformation of antitumor acridinone C-1305 but not C-1311 via selective cellular expression of UGT1A10 increases cytotoxic response: implications for clinical use.
    Pawlowska M; Chu R; Fedejko-Kap B; Augustin E; Mazerska Z; Radominska-Pandya A; Chambers TC
    Drug Metab Dispos; 2013 Feb; 41(2):414-21. PubMed ID: 23160818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10.
    Watanabe Y; Nakajima M; Yokoi T
    Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
    Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
    Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs.
    Li T; Zheng Y; Fu F; Ji H; Chen X; Zhao Y; Zhao D; Li N; Zhang L
    Xenobiotica; 2011 Jul; 41(7):530-7. PubMed ID: 21524190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin.
    Xin H; Xia YL; Hou J; Wang P; He W; Yang L; Ge GB; Xu W
    J Pharm Pharmacol; 2015 Dec; 67(12):1673-81. PubMed ID: 26407805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavin monooxygenases, FMO1 and FMO3, not cytochrome P450 isoenzymes, contribute to metabolism of anti-tumour triazoloacridinone, C-1305, in liver microsomes and HepG2 cells.
    Fedejko-Kap B; Niemira M; Radominska-Pandya A; Mazerska Z
    Xenobiotica; 2011 Dec; 41(12):1044-55. PubMed ID: 21859392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of UDP-glucuronidation by acridinone antitumor agents C-1305 and C-1311 in HepG2 and HT29 cell lines, despite slight impact in noncellular systems.
    Bejrowska A; Pawłowska M; Mróz A; Mazerska Z
    Pharmacol Rep; 2018 Jun; 70(3):470-475. PubMed ID: 29649683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10.
    Sten T; Qvisen S; Uutela P; Luukkanen L; Kostiainen R; Finel M
    Drug Metab Dispos; 2006 Sep; 34(9):1488-94. PubMed ID: 16763014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The imidazoacridinone antitumor drug, C-1311, is metabolized by flavin monooxygenases but not by cytochrome P450s.
    Potega A; Dabrowska E; Niemira M; Kot-Wasik A; Ronseaux S; Henderson CJ; Wolf CR; Mazerska Z
    Drug Metab Dispos; 2011 Aug; 39(8):1423-32. PubMed ID: 21555506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10.
    Ramírez J; Mirkov S; House LK; Ratain MJ
    Drug Metab Dispos; 2015 Jul; 43(7):928-35. PubMed ID: 25870101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
    Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
    Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms.
    Uchihashi S; Fukumoto H; Onoda M; Hayakawa H; Ikushiro S; Sakaki T
    Drug Metab Dispos; 2011 May; 39(5):803-13. PubMed ID: 21346002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance.
    Kemp DC; Fan PW; Stevens JC
    Drug Metab Dispos; 2002 Jun; 30(6):694-700. PubMed ID: 12019197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases.
    Zielinska A; Lichti CF; Bratton S; Mitchell NC; Gallus-Zawada A; Le VH; Finel M; Miller GP; Radominska-Pandya A; Moran JH
    J Pharmacol Exp Ther; 2008 Jan; 324(1):139-48. PubMed ID: 17921187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucuronidation of linoleic acid diols by human microsomal and recombinant UDP-glucuronosyltransferases: identification of UGT2B7 as the major isoform involved.
    Jude AR; Little JM; Czernik PJ; Tephly TR; Grant DF; Radominska-Pandya A
    Arch Biochem Biophys; 2001 May; 389(2):176-86. PubMed ID: 11339806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases.
    Bratton SM; Mosher CM; Khallouki F; Finel M; Court MH; Moran JH; Radominska-Pandya A
    J Pharmacol Exp Ther; 2012 Jan; 340(1):46-55. PubMed ID: 21972237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipramine N-glucuronidation in human liver microsomes: biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms.
    Nakajima M; Tanaka E; Kobayashi T; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2002 Jun; 30(6):636-42. PubMed ID: 12019188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.
    Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.